KRAS and neoplasm: Other enriched processes in this tumor phenotype included KRAS, a critical regulator of oncogenic properties, cell–cell adhesion, androgen feedback, and stress responses to hypoxia and UV exposure (Figure 4A and Supplementary Table 3).